{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:25:51Z","timestamp":1791897951597,"version":"4.3.4"},"reference-count":29,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Soc. Bras. Med. Trop."],"DOI":"10.1590\/0037-8682-0277-2022","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T13:28:23Z","timestamp":1674826103000},"source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of in-vitro susceptibility of \u00df-lactam-resistant Gram-negative bacilli to ceftazidime-avibactam and ceftolozane-tazobactam from clinical samples of a general hospital in southern Brazil"],"prefix":"10.1590","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6273-7508","authenticated-orcid":false,"given":"Thaisa Noceti","family":"Carvalho","sequence":"first","affiliation":[{"name":"Universidade da Regi\u00e3o de Joinville,  Brasil; Dona Helena Hospital,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-2278","authenticated-orcid":false,"given":"Vanessa Cristine","family":"Kobs","sequence":"additional","affiliation":[{"name":"Universidade da Regi\u00e3o de Joinville,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2356-0054","authenticated-orcid":false,"given":"Daniela","family":"Hille","sequence":"additional","affiliation":[{"name":"Universidade da Regi\u00e3o de Joinville,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5636-2703","authenticated-orcid":false,"given":"Roseneide Campos","family":"Deglmann","sequence":"additional","affiliation":[{"name":"Universidade da Regi\u00e3o de Joinville,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-6267","authenticated-orcid":false,"given":"Luiz Henrique","family":"Melo","sequence":"additional","affiliation":[{"name":"Universidade da Regi\u00e3o de Joinville,  Brasil; Dona Helena Hospital,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1750-9132","authenticated-orcid":false,"given":"Paulo Henrique Condeixa de","family":"Fran\u00e7a","sequence":"additional","affiliation":[{"name":"Universidade da Regi\u00e3o de Joinville,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2023]]},"reference":[{"issue":"5","key":"ref1","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cmi.2015.12.002","article-title":"The negative impact of antibiotic resistance","volume":"22","author":"Friedman ND","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jgar.2019.05.028","article-title":"New Delhi Metallo-\u03b2-lactamase and other mechanisms of carbapenemases among Enterobacteriaceae in rural South India","volume":"18","author":"Sekar R","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41426-018-0033-1","article-title":"Rapid rise of the ESBL and mcr-1 genes in Escherichia coli of chicken origin in China, 2008-2014","volume":"7","author":"Wu C","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vetmic.2018.05.017","article-title":"Prevalence and molecular features of ESBL\/pAmpC-producing Enterobacteriaceae in healthy and diseased companion animals in Brazil","volume":"221","author":"Melo LC","year":"2018","journal-title":"Vet Microbiol"},{"key":"ref5","series-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","year":"2017"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijid.2017.06.007","article-title":"Comparison of antimicrobial activity between ceftolozane - tazobactam and ceftazidime - avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa","volume":"62","author":"Alatoom A Elsayed H","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s15010-017-1096-y","article-title":"Pharmacological aspects and spectrum of action of ceftazidime-avibactam: a systematic review","volume":"46","author":"Tuon FF","year":"2017","journal-title":"Infection"},{"key":"ref8","series-title":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria. Parecer p\u00fablico de avalia\u00e7\u00e3o de medicamento-aprova\u00e7\u00e3o","year":"2018"},{"issue":"5","key":"ref9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bjid.2017.03.008","article-title":"The in vitro activity of ceftazidime-avibactam against 417 Gram-negative bacilli collected in 2014 and 2015 at a teaching hospital in S\u00e3o Paulo, Brazil","volume":"21","author":"Rossi F","year":"2017","journal-title":"Braz J Infect Dis"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/AAC.03042-15","article-title":"In vitro susceptibility to ceftazidime-avibactam of carbapenem-nonsusceptible Enterobacteriaceae isolates collected during the INFORM global surveillance study (2012 to 2014)","volume":"60","author":"Jonge BLM","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"ref11","first-page":"1058","article-title":"In vitro activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa causing urinary, intra-abdominal and lower respiratory tract infections in intensive care units in Portugal: the STEP multicentre study","volume":"55","author":"Garcia-Fernandez S","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.diagmicrobio.2018.11.021","article-title":"Antimicrobial activity of ceftolozane-tazobactam tested against gram-negative contemporary (2015-2017) isolates from hospitalized patients with pneumonia in US medical centers","volume":"94","author":"Carvalh\u00e3es CG","year":"2019","journal-title":"Diagn Microbiol and Infect Dis"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.diagmicrobio.2019.01.012","article-title":"Evaluation of in vitro activity of ceftolozane-tazobactam compared to other antimicrobial agents against Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"94","author":"Gherardi G","year":"2019","journal-title":"Diagn Microbiol and Infect Dis"},{"issue":"5","key":"ref14","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ijantimicag.2019.01.010","article-title":"Efficacy of ceftolozane\/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model","volume":"53","author":"G\u00f3mez-Junyent J","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"ref15","first-page":"11492","article-title":"In vitro activity of ceftolozane\/tazobactam against phenotypically defined extended-spectrum \u03b2-lactamase (ESBL)-positive isolates of Escherichia coli and Klebsiella pneumoniae isolated from hospitalized patients (SMART 2016)","volume":"96","author":"Karlowsky JA","year":"2019","journal-title":"Diagn Microbiol and Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jgar.2019.12.009","article-title":"Resistance to ceftazidime-avibactam and underlying mechanisms","volume":"22","author":"Wang Y","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"ref17","series-title":"Nota T\u00e9cnica n 01\/2013: Medidas de preven\u00e7\u00e3o e controle de infec\u00e7\u00f5es por enterobact\u00e9rias multirresistentes","year":"2013"},{"issue":"4","key":"ref18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1590\/0037-8682-0002-2016","article-title":"The role of the genetic elements bla oxa and ISAba1 in the Acinetobacter calcoaceticus-Acinetobacter baumannii complex in carbapenem resistance in the hospital setting","volume":"49","author":"Kobs VC","year":"2016","journal-title":"Rev Soc Bras Med Trop"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1099\/00207713-41-2-324","article-title":"Phylogenetic analysis of aquaspirillum magnetotacticum using polymerase chain reaction-amplified 16S rRNA-specific DNA","volume":"41","author":"Eden PA","year":"1991","journal-title":"Inter Journal Sys Bacteriol"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13054-016-1320-7","article-title":"Antibiotic strategies in the era of multidrug resistance","volume":"20","author":"Karam G","year":"2016","journal-title":"Crit Care"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"Van Duin D","year":"2016","journal-title":"Virulence"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos AP","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"20","key":"ref23","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1021\/acs.jmedchem.7b00215","article-title":"Pharmaceutical approaches to target antibiotic resistance mechanisms","volume":"60","author":"Schillaci D","year":"2017","journal-title":"J Med Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3389\/fmicb.2020.01365","article-title":"Reduced ceftazidime-avibactam susceptibility in KPC-producing Klebsiella pneumoniae from patients without ceftazidime-avibactam use history - A Multicenter Study in China","volume":"11","author":"Cui X","year":"2020","journal-title":"Front Microbiol"},{"key":"ref25","first-page":"15","article-title":"Drug resistance pattern of bacterial pathogens of Enterobacteriaceae family","volume":"4","author":"Sah BS","year":"2017","journal-title":"TUJM"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00160-19","article-title":"Comparative activities of ceftazidime-avibactam and ceftolozane-tazobactam against Enterobacteriaceae isolates producing extended-spectrum \u03b2 - lactamases from U.S. hospitals","volume":"63","author":"Castanheira M","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"ref27","first-page":"68","article-title":"Antimicrobial activity of ceftolozane-tazobactam against multidrug-resistant and extensively drugresistant Pseudomonas aeruginosa clinical isolates from a Spanish hospital","volume":"32","author":"Lop\u00e9z-Calleja AI","year":"2019","journal-title":"Rev Esp Quimioter"},{"issue":"1","key":"ref28","first-page":"1026","article-title":"Ceftolozane\/tazobactam resistance and mechanisms in carbapenem-nonsusceptible Pseudomonas aeruginosa","volume":"6","author":"Qi-Min Teo J","year":"2021","journal-title":"mSphere"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bjid.2020.04.004","article-title":"Evaluation of in vitro activity of ceftolozane-tazobactam against recent clinical bacterial isolates from Brazil - the EM200 study","volume":"24","author":"Tuon FF","year":"2020","journal-title":"Braz J Infect Dis"}],"container-title":["Revista da Sociedade Brasileira de Medicina Tropical"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0037-86822023000100303&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T13:28:53Z","timestamp":1674826133000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0037-86822023000100303&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":29,"alternative-id":["S0037-86822023000100303"],"URL":"https:\/\/doi.org\/10.1590\/0037-8682-0277-2022","relation":{},"ISSN":["1678-9849","0037-8682"],"issn-type":[{"value":"1678-9849","type":"electronic"},{"value":"0037-8682","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e0277-2022"}}